KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Equity Income (2016 - 2025)

National Health Investors filings provide 11 years of Equity Income readings, the most recent being $1.7 million for Q4 2025.

  • On a quarterly basis, Equity Income rose 82700.0% to $1.7 million in Q4 2025 year-over-year; TTM through Mar 2026 was $3.2 million, a 396.92% increase, with the full-year FY2025 number at $3.7 million, up 816.0% from a year prior.
  • Equity Income hit $1.7 million in Q4 2025 for National Health Investors, up from $73000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $1.7 million in Q4 2025 to a low of -$909000.0 in Q2 2021.
  • Median Equity Income over the past 5 years was $236000.0 (2024), compared with a mean of $243933.3.
  • Biggest five-year swings in Equity Income: tumbled 100.36% in 2024 and later soared 82700.0% in 2025.
  • National Health Investors' Equity Income stood at $729000.0 in 2021, then tumbled by 95.75% to $31000.0 in 2022, then skyrocketed by 1690.32% to $555000.0 in 2023, then tumbled by 100.36% to -$2000.0 in 2024, then soared by 82700.0% to $1.7 million in 2025.
  • The last three reported values for Equity Income were $1.7 million (Q4 2025), $73000.0 (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.